These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16124239)

  • 1. Spatial and temporal variability of cytotoxic metabolites in populations of the New Zealand sponge Mycale hentscheli.
    Page M; West L; Northcote P; Battershill C; Kelly M
    J Chem Ecol; 2005 May; 31(5):1161-74. PubMed ID: 16124239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metagenomic Exploration of the Marine Sponge
    Storey MA; Andreassend SK; Bracegirdle J; Brown A; Keyzers RA; Ackerley DF; Northcote PT; Owen JG
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peloruside A: a potent cytotoxic macrolide isolated from the new zealand marine sponge Mycale sp.
    West LM; Northcote PT; Battershill CN
    J Org Chem; 2000 Jan; 65(2):445-9. PubMed ID: 10813954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial and temporal variability of the bacterial community in different chemotypes of the New Zealand marine sponge Mycale hentscheli.
    Anderson SA; Northcote PT; Page MJ
    FEMS Microbiol Ecol; 2010 Jun; 72(3):328-42. PubMed ID: 20412301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peloruside E (22-Norpeloruside A), a Pelorusane Macrolide from the New Zealand Marine Sponge Mycale hentscheli, Retains Microtubule-Stabilizing Properties.
    Hong SW; Singh AJ; Patel V; Russell ER; Field JJ; Miller JH; Northcote PT
    J Nat Prod; 2018 Sep; 81(9):2125-2128. PubMed ID: 30188708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity.
    Singh AJ; Xu CX; Xu X; West LM; Wilmes A; Chan A; Hamel E; Miller JH; Northcote PT; Ghosh AK
    J Org Chem; 2010 Jan; 75(1):2-10. PubMed ID: 19957922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-stabilizing drugs from marine sponges: focus on peloruside A and zampanolide.
    Miller JH; Singh AJ; Northcote PT
    Mar Drugs; 2010 Mar; 8(4):1059-79. PubMed ID: 20479967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycalamide D, a new cytotoxic amide from the New Zealand marine sponge Mycale species.
    West LM; Northcote PT; Hood KA; Miller JH; Page MJ
    J Nat Prod; 2000 May; 63(5):707-9. PubMed ID: 10843597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiproducer microbiome generates chemical diversity in the marine sponge
    Rust M; Helfrich EJN; Freeman MF; Nanudorn P; Field CM; Rückert C; Kündig T; Page MJ; Webb VL; Kalinowski J; Sunagawa S; Piel J
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9508-9518. PubMed ID: 32291345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity studies of the pelorusides: new congeners and semi-synthetic analogues.
    Singh AJ; Razzak M; Teesdale-Spittle P; Gaitanos TN; Wilmes A; Paterson I; Goodman JM; Miller JH; Northcote PT
    Org Biomol Chem; 2011 Jun; 9(12):4456-66. PubMed ID: 21512693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel cytotoxic sponge metabolite peloruside A, structurally similar to bryostatin-1, has unique bioactivity independent of protein kinase C.
    Hood KA; Bäckström BT; West LM; Northcote PT; Berridge MV; Miller JH
    Anticancer Drug Des; 2001; 16(2-3):155-66. PubMed ID: 11962513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
    Kanakkanthara A; Northcote PT; Miller JH
    Nat Prod Rep; 2016 Apr; 33(4):549-61. PubMed ID: 26867978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic, semisynthetic and natural analogues of peloruside A.
    Brackovic A; Harvey JE
    Chem Commun (Camb); 2015 Mar; 51(23):4750-65. PubMed ID: 25642465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine.
    Hood KA; West LM; Northcote PT; Berridge MV; Miller JH
    Apoptosis; 2001 Jun; 6(3):207-19. PubMed ID: 11388670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial variability in secondary metabolites of the indo-pacific sponge Stylissa massa.
    Rohde S; Gochfeld DJ; Ankisetty S; Avula B; Schupp PJ; Slattery M
    J Chem Ecol; 2012 May; 38(5):463-75. PubMed ID: 22569832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycapolyols A-F, new cytotoxic metabolites of mixed biogenesis from the marine sponge Mycale izuensis.
    Phuwapraisirisan P; Matsunaga S; Fusetani N
    Org Lett; 2005 May; 7(11):2233-6. PubMed ID: 15901177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mycalolides from the marine sponge Mycale magellanica and their interconversion.
    Matsunaga S; Sugawara T; Fusetani N
    J Nat Prod; 1998 Sep; 61(9):1164-7. PubMed ID: 9748392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of natural toxicity in sponges: toxicity bioassay versus compound quantification.
    Martí R; Fontana A; Uriz MJ; Cimino G
    J Chem Ecol; 2003 Jun; 29(6):1307-18. PubMed ID: 12918917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First record of sponge distribution in the Persian Gulf, (Hengam Island, Iran).
    Sadeghi P; Savari A; Yavari V; Devin ML
    Pak J Biol Sci; 2008 Nov; 11(21):2521-4. PubMed ID: 19205276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Report on Chitin in a Non-Verongiid Marine Demosponge: The Mycale euplectellioides Case.
    Żółtowska-Aksamitowska S; Shaala LA; Youssef DTA; Elhady SS; Tsurkan MV; Petrenko I; Wysokowski M; Tabachnick K; Meissner H; Ivanenko VN; Bechmann N; Joseph Y; Jesionowski T; Ehrlich H
    Mar Drugs; 2018 Feb; 16(2):. PubMed ID: 29461501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.